RRML - Acute myeloid leukemia treatment – between therapeutic benefit and iatrogenic pathology – case report

RRML - Acute myeloid leukemia treatment – between therapeutic benefit and iatrogenic pathology – case report

Main page News RJLabM Credits Archive

Current issue Ahead of print List of published issues 2025

Nr.4/2024 Nr.3/2024 Nr.2/2024 Nr.1/2024 Supplement 1/2024

Nr.4/2023 Nr.3/2023 Nr.2/2023 Nr.1/2023 Supplement 1/2023

Nr.4/2022 Nr.3/2022 Nr.2/2022 Nr.1/2022 Supplement 1/2022

Nr.4/2021 Nr.3/2021 Nr.2/2021 Nr.1/2021

Nr.4/2020 Nr.3/2020 Nr.2/2020 Nr.1/2020 Supplement 1/2020

Nr.4/2019 Nr.3/2019 Nr.2/2019 Nr.1/2019 Supplement 1/2019

Nr.4/2018 Nr.3/2018 Nr.2/2018 Nr.1/2018 Supplement 1/2018 Supplement 2/2018 Supplement 3/2018

Nr.4/2017 Nr.3/2017 Nr.2/2017 Nr.1/2017 Supplement 1/2017

Nr.4/2016 Nr.3/2016 Nr.2/2016 Nr.1/2016 Supplement 1/2016

Nr.4/2015 Nr.3/2015 Nr.2/2015 Nr.1/2015 Supplement 1/2015

Nr.4/2014 Nr.3/2014 Nr.2/2014 Nr.1/2014 Supplement 1/2014

Nr.4/2013 Nr.3/2013 Nr.2/2013 Nr.1/2013 Supplement 1/2013

Nr.4/2012 Nr.3/2012 Nr.2/2012 Nr.1/2012 Supplement 1/2012

Nr.4/2011 Nr.3/2011 Nr.2/2011 Nr.1/2011 Supplement 1/2011

Nr.4/2010 Nr.3/2010 Nr.2/2010 Nr.1/2010 Supplement 1/2010

Nr.4/2009 Nr.3/2009 Nr.2/2009 Nr.1/2009 Supplement 1/2009

Nr.4/2008 Nr.3/2008 Nr.2/2008 Nr.1/2008 Supplement 1/2008

Nr.4/2007 Nr.3/2007 Nr.2/2007 Nr.1/2007

Nr.4/2006 Nr.3/2006 Nr.2/2006 Nr.1/2006

Instructions for authors

Instructions Instructions for authors Publication ethics

Statement of Informed Consent Statement of Human and Animal Rights Conflict of Interest Statement Scientific misconduct Authors' contributions

Article proof annotations Publication fees Downloads License to publish Cover letter Manuscript template file Disclosure - Conflict of interest Peer-review criteria About plagiarism

Online applications

Send an article Online payments

Administration Editorial board Scientific reviewers

Editorial process Editorial policy Privacy policy RJLabM Rules Editors commitment Contact

Committee on Publication Ethics (COPE)International Committee of Medical Journal Editors Acta Marisiensis Seria Medica Bacteriologia, Virusologia, Parazitologia, Epidemiologia Biochemia Medica Clinical Chemistry and Laboratory Medicine Clinical Chemistry Clinica Chimica Acta Documenta Haematologica Romanian Journal of Morphology and Embryology Biostatistics and web search strategies (Romanian)How to spot a statistical problem Statistical Analyses and Methods in the Published Literature

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Top 10 downloaded articles - April 2025 -

Romanian Review of Laboratory ...	3
Investigation of cytokine chan...	2
Coeliac disease and variable i...	1
Incidence and clinical signifi...	1
Vitamin K and bone metabolism...	1
Methicillin-resistant Staphylo...	1
Immunologic and Biochemical Ef...	1
Serum tumor markers for screen...	1
Peculiar hyper-IgM syndrome. C...	1
In Vivo Testing of Xenogeneic ...	1

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 10(1)/2008

Acute myeloid leukemia treatment – between therapeutic benefit and iatrogenic pathology – case report

Anca Bacârea, Bogdana Dorcioman, Minodora Dobreanu, Galafteon Oltean, Smaranda Demian, Anamaria Rusu, Maria T. Dogaru, Camil Eugen Vari

Abstract:

The treatment of acute myeloid leukemia specific includes antracyclinic compounds and cytrabine; the limitation factor of clinical efficacy is dose-related drug toxicity. Beside cytotoxic specific adverse reactions, the claimed medication presents a target cardiac toxicity. This paper presents a clinical case, the relationship between medication and iatrogenic risks and also patient prognosis.

Keywords: acute myeloid leukemia,treatment,prognostic

Download full text PDF
(917 KB)

Bacârea A, Dorcioman B, Dobreanu M, Oltean G, Demian S, Rusu A, et al. Acute myeloid leukemia treatment – between therapeutic benefit and iatrogenic pathology – case report. Rev Romana Med Lab. 2008;10(1):33-8